Daniel Misch

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Delayed Solitary Adrenal Metastasis in Malignant Pleural Mesothelioma with Long-Term Survival under Immunotherapy.

Delayed Solitary Adrenal Metastasis in Malignant Pleural Mesothelioma with Long-Term Survival under Immunotherapy.

Journal: Pneumologie (Stuttgart, Germany)

Published: May 19, 2026

Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer.

Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 23, 2026

Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].

Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 24, 2024

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 06, 2023

Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.

Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.

Journal: Future oncology (London, England)

Published: November 02, 2023

Axenic Long-Term Cultivation of Pneumocystis jirovecii.

Axenic Long-Term Cultivation of Pneumocystis jirovecii.

Journal: Journal of fungi (Basel, Switzerland)

Published: July 19, 2023

Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer - A multicenter observational analysis.

Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer - A multicenter observational analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 11, 2023

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Journal: International journal of molecular sciences

Published: September 01, 2022

Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial.

Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 25, 2022

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 19, 2022

Autoimmune disorders and paraneoplastic syndromes in thymoma.

Autoimmune disorders and paraneoplastic syndromes in thymoma.

Journal: Journal of thoracic disease

Published: January 15, 2021

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.

Journal: Clinical lung cancer

Published: November 19, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026